SAM
BCAX

SEB Asset Management’s Bicara Therapeutics BCAX Stock Holding History

SEB Asset Management’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.89M Buy
+232,156
New +$5.18M 0.03% 404

Other funds holding BCAX

RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AG
Ascent Group Virginia Beach, Virginia $3.34B AUM 27.33% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SEB Asset Management's BCAX Position: Q2 2026 in Review

SEB Asset Management opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 232,156 shares worth $6.89M. The stake represents 0.03% of the portfolio and ranks #404 among its holdings.

28 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • SEB Asset Management held 232,156 shares of Bicara Therapeutics worth $6.89M as of Q2 2026.
  • Bicara Therapeutics was a new SEB Asset Management position in Q2 2026.
  • Bicara Therapeutics made up 0.03% of SEB Asset Management's portfolio in Q2 2026, its #404 holding.
  • 28 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.